All you need to get started with ETF selection and analysis. Create your account now →

Help us improve your experience. Please confirm your investor type:

ETF What's Up

Don’t Miss a Move in the ETF Market

Sign up and keep track of everything that moved the ETF industry this week. From new launches to regulatory shifts across the Atlantic.

ETF What's Up

You may unsubscribe at any time by clicking the “unsubscribe” link within the emailed newsletter. By signing up, you agree to our Privacy Policy and Terms and Conditions.

248270

Mirae Asset TIGER SYNTH-GLOBAL HEALTHCARE ETF

Passive ETFEquity
Not rated

The 248270 Exchange Traded Fund (ETF) is provided by Mirae Asset Global Investments. It is built to track an index: S&P Global 1200 Healthcare Index. This ETF provides synthetic exposure, by owning its shares you earn the return of the index indirectly through the use of derivatives or a swap (i.e. a contract with a financial institution which delivers the return of the index). The dividend policy is capitalization.

Advertisement

Advertisement

₩25,255
-₩515 (-2.00%) yesterday
12:00 AM 10/02/26 Closed
1D price range
₩25,255₩25,525
52W price range
₩23,240₩29,855
YTD Perf.
-1.18%
YTD Flows
Annualized volatility
Fund AuM
€20M
Share class AuM
€20M
TTM Yield
-
Tracking Error
Tracking Difference
ISIN
KR7248270001
TER
0.4%
Inception date
7/1/2016
Replication method
Dividend policy
Compare similar ETFs
API
PerformanceDec 30, 2025 - Oct 1, 2026
-5%0%5%10%JANMARMAYJULSEP
Flows
Join for free to unlock

No content available for this fund

Latest 248270 news

No content available for this fund

FAQ about 248270

248270 is a Passive ETF. This ETF provides exposure to Large Cap Global Health Care Equities.
248270 tracks the S&P Global 1200 Healthcare Net Total Return Index - USD, through a unfunded swap replication method.
248270 carries a total expense ratio (TER) of 0.4%, indicating the annual cost for holding the fund.
248270 was introduced to the market on July 1, 2016. It trades on Iran, Islamic Republic Of, among other exchanges
Mirae Asset TIGER SYNTH-GLOBAL HEALTHCARE ETF, 248270, is provided by Mirae Asset Global Investments. Learn more about Mirae Asset Global Investments here.
248270 oversees €20M in assets as of October 1, 2026.
248270 follows a capitalizing, meaning it reinvests income within the fund. As of October 1, 2026, its 12-month trailing yield was 0.28%.
The base currency of 248270 is KRW.

No content available for this fund

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight